Replanteamiento de la expresión de CLDN18.2 en el tratamiento del cáncer gástrico

Peng Luo1, Hank Z H Wong2, Dan Shan3

  • 1Jiangnan University Smart Healthcare Joint Laboratory, Donghai County People's Hospital, Lianyungang, China; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Lancet (London, England)
|January 10, 2026
PubMed
Resumen

No abstract available in PubMed .